BCOP Test - Novel Treatments for Neuroendocrine Tumors |
|
09/28/2020 - 4:00pm to 09/28/2021 - 12:00am |
Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Bladder Cancer |
1.00 |
10/08/2020 - 12:00am to 10/08/2021 - 12:00am |
Recorded Presentation from the NCCN Pharmacy Updates: Novel Treatments for Neuroendocrine Tumors |
1.00 |
10/08/2020 - 12:00am to 09/28/2021 - 12:00am |
NCCN Guidelines® Insights - Colorectal Cancer Screening, Version 2.2020 |
1.00 |
10/10/2020 - 12:00am to 10/10/2021 - 12:00am |
BCOP Test - Establishing a Place in Therapy for Biosimilars in Oncology |
|
10/28/2020 - 1:30pm to 10/28/2021 - 12:00am |
Optimizing Outpatient Care in Hematopoietic Cell Transplant Patients |
0.75 |
10/30/2020 - 12:00am to 10/30/2021 - 12:00am |
Strategies to Reduce Clostridioides Difficile Infection in Hematologic Malignancies |
0.75 |
10/30/2020 - 12:00am to 10/30/2021 - 12:00am |
Management of Cardiac Complications in Hematologic Malignancies |
0.75 |
10/30/2020 - 12:00am to 10/30/2021 - 12:00am |
Advances and Innovations in Multiple Myeloma |
0.75 |
10/30/2020 - 12:00am to 10/30/2021 - 12:00am |
Lymphoma 101: The Plot Thickens |
0.50 |
10/30/2020 - 12:00am to 10/30/2021 - 12:00am |
Navigating the Jargon of Molecular Testing |
0.50 |
10/30/2020 - 12:00am to 10/30/2021 - 12:00am |
Controversies in the Management of Early-Stage Hodgkin Lymphoma |
0.50 |
10/30/2020 - 12:00am to 10/30/2021 - 12:00am |
Updates in the Management of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Sequencing Therapy and the Role of MRD Testing |
0.50 |
10/30/2020 - 12:00am to 10/30/2021 - 12:00am |
Challenges and Opportunities in Marginal Zone Lymphoma: Implications of Biology on Treatment |
0.50 |
10/30/2020 - 12:00am to 10/30/2021 - 12:00am |
Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Mantle Cell Lymphoma: Is it Time to Consider CAR T for All? |
0.50 |
10/30/2020 - 12:00am to 10/30/2021 - 12:00am |